Vivimed Labs Declines After Lender SBI Initiates Forensic Audit

March 28, 2022, 7:10 AM UTC

Shares of Vivimed Labs fall after the maker of specialty chemicals says lender State Bank of India has initiated a forensic audit following the company’s proposal to restructure its debt.

  • Shares fall as much as 4.5%, set for 4th day of decline
  • Vivimed Labs says it’s mandatory for lenders to conduct a forensic audit
  • Co. has strong internal controls and an effective audit system, according to a statement filed on local stock exchanges

To view the source of this information click here

To contact the reporter on this story:
Ashutosh Joshi in Mumbai at ajoshi86@bloomberg.net

To contact the editors responsible ...

Learn more about Bloomberg Tax or Log In to keep reading:

See Breaking News in Context

From research to software to news, find what you need to stay ahead.

Already a subscriber?

Log in to keep reading or access research tools and resources.